Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (2 quarters reported)
$129M in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2013. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| 0 0 | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 1 quarters.
quarter ended September 30, 2013 · filed October 16, 2013
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| HM Health Mgmt Associates Inc-a | Exited | −310,000 | −$4.87M | — |
| SJ St Jude Medical Inc | Exited | −75,000 | −$3.42M | — |
| Molina Healthcare Inc | Exited | −90,000 | −$3.35M | — |
| Icon PLC | Exited | −90,000 | −$3.19M | — |
| A Aetna Inc | Exited | −50,000 | −$3.18M | — |
| Centene Corp | Exited | −60,000 | −$3.15M | — |
| Bristol-myers Squibb Co | Exited | −70,000 | −$3.13M | — |
| Community Health Systems Inc | Exited | −65,000 | −$3.05M | — |
| BI Biogen Idec Inc | Exited | −14,000 | −$3.01M | — |
| Thermo Fisher Scientific Inc | Exited | −35,000 | −$2.96M | — |
Showing the 10 largest of 62 changes.
Loading...
